Table 1 Clinical and biochemical characteristics of study subjects
| Â | CAD subjects (n = 102) | Control subjects (n = 104) | p-value |
|---|---|---|---|
Age (years) | 50.1 ± 5.3 | 47.5 ± 3.7 | <0.02 |
Sex (M/F) | 96/6 | 89/15 | NS |
Body Mass Index (kg/m2) | 26.9 ± 3.2 | 26.4 ± 3.7 | NS |
Smokers (%) | 85.2% | 52.5% | <0.002 |
Hypertensive (%) | 22.5 | 14.5 | NS |
Total cholesterol (mg/dl) | 197.3 ± 33.7 | 199.8 ± 41.7 | NS |
HDL-cholesterol (mg/dl) | 27.6 ± 8.2 | 38.1 ± 10.2 | <0.0001 |
LDL-cholesterol (mg/dl) | 145.6 ± 36.9 | 119.5 ± 32.9 | <0.0001 |
Total triglycerides (mg/dl) | 211.3 ± 63.6 | 188.1 ± 97.4 | <0.0006 |
APO AI (mg/dl) | 107.2 ± 17.5 | 129.1 ± 23.1 | <0.0001 |
APO B (mg/dl) | 117.7 ± 25.5 | 101.1 ± 24.9 | <0.01 |
APO AII (mg/dl) | 38.7 ± 6.4 | 43.9 ± 9.0 | <0.001 |
APO CII (mg/dl) | 4.03 ± 1.4 | 3.99 ± 1.6 | NS |
APO CIII (mg/dl) | 12.1 ± 2.3 | 13.1 ± 3.2 | <0.008 |
APO E (mg/dl) | 8.6 ± 2.1 | 10.2 ± 3.3 | <0.0001 |